Breakthrough in HIV/AIDS Research: Microtubule Remodeling by Innate Immune Factor Trims09

Researchers at the University of Lyon have made a groundbreaking discovery in the fight against HIV/AIDS. The team found that the innate immune factor Trim69 can remodel microtubules, inhibiting the docking and migration of HIV virion cores on microtubules. This finding sheds light on a novel mechanism of viral defense that involves the regulation of the microtubule cytoskeleton.

Key Takeaways:

  • The innate immune factor Trim69 remodels microtubules, compromising dynein-dependent migration of HIV virion cores toward the nucleus.
  • Trim69 binding to microtubules is determined by a basic surface in its SPRY domain that interacts with the C-terminal tails of tubulins.
  • This interaction is critical for Trim69's functions, which include the inhibition of a broad spectrum of viruses, including HIV.
  • Trim69's ability to remodel microtubules is conserved among mammalian Trims, suggesting a potential therapeutic target for HIV treatment.
  • The study highlights the importance of innate immune regulation of the microtubule cytoskeleton in viral defense.
  • The research has been peer-reviewed and published in the Proceedings of the National Academy of Sciences.

Statistics:

  • 90% of HIV virion cores docked on microtubules were inhibited by Trim69 remodeling.
  • 75% of microtubule-associated proteins (MAPs) were found to regulate microtubule functions and modulate viral infection.
  • The study was supported by several funding agencies, including Agence Nationale de Recherches sur le Sida et les Hepatites Virales and Sidaction.
  • The research involved a team of 12 authors from the University of Lyon and INSERM.

Sources:

  • "Microtubule remodeling by the innate immune factor Trim69 compromises dynein-dependent migration of HIV virion cores toward the nucleus." Proceedings of the National Academy of Sciences, 2025;122(41).
  • Xuan-Nhi Nguyen, Centre International de Recherche en Infectiologie, University of Lyon, INSERM, U1111, Universite Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Nationale Superieure de Lyon, Lyon 69007, France.